EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Longer-term outcomes of gastroesophageal reflux disease treated with magnetic sphincter augmentation

Aiysha Puri, Sue Steven, Sheraz R Markar, Nicholas Boyle

Diseases of the Esophagus · 2023

DOI: 10.1093/dote/doad014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diseases of the Esophagus, 2023. Verfasst von Aiysha Puri und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Cancer, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Gastroesophageal Reflux, Laparoscopy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Surgical intervention for gastroesophageal reflux disease (GERD) has historically been limited to fundoplication. Magnetic sphincter augmentation (MSA) is a less invasive alternative that was introduced 15 years ago, and it may have a superior side-effect profile. To date, however, there has been just a single published study reporting outcomes in a UK population. This study reports quality-of-life (QOL) outcomes and antacid use in patients undergoing MSA, with a particular focus on postoperative symptoms and those with severe reflux. A single-center cohort study was carried out to assess the QOL outcomes and report long-term safety outcomes in patients undergoing MSA. GERD-health-related quality of life (GERD-HRQL) and Reflux Symptom Index (RSI) scores were collected preoperatively, and immediately postoperatively, at 1-, 2-, 3-, and 5-year follow-up time points. All patients underwent preoperative esophagogastroduodenoscopy, impedance, and manometry. Two hundred and two patients underwent laparoscopic MSA over 9 years. The median preoperative GERD-HRQL score was 31, and the median RSI score was 17. There was a reduction in all scores from preoperative values to each time point, which was sustained at 5-year follow-up; 13% of patients had a preoperative DeMeester score of >50, and their median preoperative GERD-HRQL and RSI scores were 32 and 15.5, respectively. These were reduced to 0 at the most recent follow-up. There was a significant reduction in antacid use at all postoperative time points. Postoperative dilatation was necessary in 7.4% of patients, and the device was removed in 1.4%. Erosion occurred in no patients. MSA is safe and effective at reducing symptom burden and improving QOL scores in patients with both esophageal and laryngopharyngeal symptoms, including those with severe reflux.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastroesophageal RefluxLaparoscopyHumansQuality of LifeCohort StudiesEsophageal Sphincter, LowerAntacidsRetrospective StudiesTreatment OutcomeFundoplicationMagnetic Phenomena

Stichwörter der Autor:innen

anti-reflux surgerydiseases of the esophagusgastroesophageal reflux (GERD)health-related quality of life

Substanzen

Antacids

Autor:innen und Institutionen

  • Department of Surgery and Cancer, Imperial College London, London, UK.
  • Department of Surgery, Reflux UK, London, UK.
  • Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Nuffield Department of Surgery, University of Oxford, Oxford, UK.

Zitieren

APA

Puri, A., Steven, S., Markar, S. R., & Boyle, N. (2023). Longer-term outcomes of gastroesophageal reflux disease treated with magnetic sphincter augmentation. Diseases of the Esophagus. https://doi.org/10.1093/dote/doad014

Vancouver

Puri A, Steven S, Markar SR, Boyle N. Longer-term outcomes of gastroesophageal reflux disease treated with magnetic sphincter augmentation. Diseases of the Esophagus. 2023. doi:10.1093/dote/doad014

BibTeX
@article{Puri2023,
  author = {Puri, Aiysha and Steven, Sue and Markar, Sheraz R and Boyle, Nicholas},
  title = {Longer-term outcomes of gastroesophageal reflux disease treated with magnetic sphincter augmentation},
  journal = {Diseases of the Esophagus},
  year = {2023},
  doi = {10.1093/dote/doad014}
}
Kostenlos starten →